Use of 3-guanidinopropionic acid in the treatment and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/195 (2006.01)

Patent

CA 2073873

The present invention provides a method for treating or preventing certain metabolic disorders comprising the administra- tion of 3-guanidinopropionic acid (3-GPA). These metabolic disorders of human and animal metabolism, e.g hyperglycemia, im- paired glucose tolerance, hyperinsulinemia and insulin insensitivity, hyperamylinemia, excess adiposity, and hyperlipidemia, may occur in the following disease states: non-insulin dependent diabetes mellitus (NIDDM), obesity, hypertension and atherosclero- sis. 3-GPA may be administered admixed in the diet of farm animals or as a pharmaceutical preparation such as an oral tablet or capsule, by injection, or by implantable sustaind release devices thereby increasing the protein content of the carcass while de- creasing its fat content. This would produce muscle tissue with less fat.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 3-guanidinopropionic acid in the treatment and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 3-guanidinopropionic acid in the treatment and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3-guanidinopropionic acid in the treatment and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1811484

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.